4 ms·

Boosters are beneficial even if you’re under 45: https://www.latimes.com/science/story/2021-12-09/large-studies-shows-huge-benefit-of-covid-19-booster-shots htt

by bryan0 5y ago

Boosters are beneficial even if you’re under 45: https://www.latimes.com/science/story/2021-12-09/large-studies-shows-huge-benefit-of-covid-19-booster-shots https://www.latimes.com/science/story/2021-12-09/large-studi... Edit: critical to beneficial

MaxHoppersGhost 5y ago
Your article says they are beneficial, not critical.
- bryan0 5y ago
  Thanks I updated my comment
throwawaymedia 5y ago
[flagged]
- deleted 5y ago
  [deleted]
- MrZander 5y ago
  > Post-vaccination CAE rate was highest in young boys aged 12-15 following dose two. For boys 12-17 without medical comorbidities, the likelihood of post vaccination dose two CAE is 162.2 and 94.0/million respectively. This incidence exceeds their expected 120-day COVID-19 hospitalization rate I'm I reading this wrong? The study is concluding that this population is more likely to have a CAE if they get the vaccine than being hospitalized without the vaccine?
  - yorwba 5y ago
    Yes, that's the conclusion. You could quibble a bit and compare CAE hospitalizations instead, but they'd still exceed the expected 120-day COVID-19 hospitalization rate. On the other hand, "expected" is based on past data, and their benchmark for "high" hospitalization risk is January 2021 in the US. Depending on how much higher the current wave will go, it might retrospectively turn out to be safer to have gotten vaccinated after all, even if you're a 12-year-old boy without comorbidities.
- azth 5y ago
  Why are you being downvoted?
  - yorwba 5y ago
    Because the text in quotes is not in the paper.
  - bryan0 5y ago
    Maybe because the study has nothing to do with boosters or overall Covid risk. Myocarditis risk is lower with boosters than with 2nd shot in Israeli studies, but again the reason to get vaccinated is not just about myocarditis. More nuance and Israeli data here: https://www.statnews.com/2021/12/09/fda-expands-authorization-for-pfizers-covid-19-booster-to-cover-16-and-17-year-olds/ https://www.statnews.com/2021/12/09/fda-expands-authorizatio... (this is also about teens specifically and not <45 question in the GP)

by bryan0 5y ago

MaxHoppersGhost 5y ago

Your article says they are beneficial, not critical.

bryan0 5y ago
Thanks I updated my comment

throwawaymedia 5y ago

[flagged]

deleted 5y ago
[deleted]
MrZander 5y ago
> Post-vaccination CAE rate was highest in young boys aged 12-15 following dose two. For boys 12-17 without medical comorbidities, the likelihood of post vaccination dose two CAE is 162.2 and 94.0/million respectively. This incidence exceeds their expected 120-day COVID-19 hospitalization rate I'm I reading this wrong? The study is concluding that this population is more likely to have a CAE if they get the vaccine than being hospitalized without the vaccine?
- yorwba 5y ago
  Yes, that's the conclusion. You could quibble a bit and compare CAE hospitalizations instead, but they'd still exceed the expected 120-day COVID-19 hospitalization rate. On the other hand, "expected" is based on past data, and their benchmark for "high" hospitalization risk is January 2021 in the US. Depending on how much higher the current wave will go, it might retrospectively turn out to be safer to have gotten vaccinated after all, even if you're a 12-year-old boy without comorbidities.
azth 5y ago
Why are you being downvoted?
- yorwba 5y ago
  Because the text in quotes is not in the paper.
- bryan0 5y ago
  Maybe because the study has nothing to do with boosters or overall Covid risk. Myocarditis risk is lower with boosters than with 2nd shot in Israeli studies, but again the reason to get vaccinated is not just about myocarditis. More nuance and Israeli data here: https://www.statnews.com/2021/12/09/fda-expands-authorization-for-pfizers-covid-19-booster-to-cover-16-and-17-year-olds/ https://www.statnews.com/2021/12/09/fda-expands-authorizatio... (this is also about teens specifically and not <45 question in the GP)